These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 8753906

  • 21. [Inhibition of renin-angiotensin-aldosterone system: what evidence?].
    Mota T.
    Rev Port Cardiol; 2001 Mar; 20 Suppl 3():13-5. PubMed ID: 11409069
    [Abstract] [Full Text] [Related]

  • 22. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J.
    J Am Coll Cardiol; 2009 Nov 03; 54(19):1747-62. PubMed ID: 19874988
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Neurohormonal antagonism in heart failure: what is the optimal strategy?
    Sackner-Bernstein JD, Hart D.
    Mt Sinai J Med; 2004 Mar 03; 71(2):115-26. PubMed ID: 15029403
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pharmacotherapeutic strategy in heart failure.
    Dominiak P.
    Clin Nephrol; 2002 Jul 03; 58 Suppl 1():S2-6. PubMed ID: 12227721
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
    Sinagra G, Sabbadini G, Zecchin M, Di Lenarda A.
    G Ital Cardiol (Rome); 2007 Sep 03; 8(9):559-67. PubMed ID: 17972425
    [Abstract] [Full Text] [Related]

  • 34. [Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
    Campa PP, Puddu PE, Schiariti M, Monti F, Dawodu AA, Gentile C, Lilla Della Monica PL, Vaccaro M, De Biase L.
    Cardiologia; 1995 Dec 03; 40(12 Suppl 1):139-50. PubMed ID: 8998706
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Neurohormonal compensation processes in chronic heart failure: the effect of drugs].
    van Zwieten PA, Lie KI.
    Ned Tijdschr Geneeskd; 1994 Jun 11; 138(24):1208-13. PubMed ID: 7912411
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.